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INTRODUCTION
 
18F-AV-1451 is a recently developed tau PET ligand that has 
high affinity for paired helical filaments of hyperphosphory-
lated tau in neurofibrillary tangles. Previous studies showed 
that 18F-AV-1451 uptake was correlated with pathological tau 
staging.1,2 However, high AV-1451 retention has also been ob-
served in other conditions unrelated to tau.3-5 This ‘off-target 
binding’ includes the substantia nigra, basal ganglia, and cho-
roid plexus. A recent report also showed incidental AV-1451 
retention in the regions of meningiomas, vascular malforma-
tions, and remote infarcts.3 Nevertheless, there is little knowl-
edge regarding 18F-AV-1451 PET findings in acute or subacute 
stage of ischemic stroke patients. Herein, we report a case of 
abnormally increased uptake of AV-1451 which was shown to 
be a subacute infarction.
CASE REPORT
An 83-year-old woman who experienced three years of pro-
gressive cognitive decline and apathy visited the Memory Clinic 
at Samsung Medical Center, Seoul, Korea. She had dyslipid-
emia and had 9 years of formal education. On neurologic exam, 
she was alert and showed no focal neurological signs including 
asymmetric weakness or sensory change. She scored 13 out of 
30 on the Mini-Mental State Examination. Neuropsychological 
testing6 revealed cognitive impairment in multiple domains 
(language, visuospatial, memory, and frontal-executive dys-
function) which limited her activities of daily living. Brain MRI 
showed confluent white matter hyperintensities and diffuse 
atrophy (Fig. 1A). Amyloid PET, assessed with 18F-florbetaben 
radiotracer, was positive and no asymmetric focal high uptake 
was observed. Apolipoprotein E genotype was e2/e3. Based 
on her clinical and imaging findings, we assumed that her de-
mentia was due to mixed etiology: Alzheimer’s disease and 
small vessel disease. 
She further underwent 18F-AV-1451 PET to search for distri-
bution of paired helical filament tau. Using cerebellar gray mat-
ter as a reference region, we created AV-1451 standardized up-
take value ratio images based on mean uptake over 90−110 min 
post-injection. AV-1451 uptake was observed in the bilateral 
medial temporal, lateral temporal, and inferior parietal areas, 
with the overall pattern looking similar to that of Alzheimer’s dis-
ease.7,8 However, a focal hot uptake in the left primary sensory 
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18F-AV-1451 is a tau PET ligand that has high affinity for paired helical filament tau. However, various off-target bindings unrelated 
to tau have also been reported. Herein, we report a case of 83-year-old woman, who showed abnormal uptake of AV-1451 that 
was shown to be subacute infarction. Clinicians should recognize that increased uptake of AV-1451 may be related to stroke.
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cortex was very unusual (Fig. 1B). This finding was unexpect-
ed because there were no relevant symptoms or signs and no 
structural lesions in that area on brain MRI, taken 20 days be-
fore the 18F-AV-1451 PET (Fig. 1A). We re-evaluated the brain 
MRI 30 days after 18F-AV-1451 PET and found a subacute infarc-
tion in the left primary sensory cortex (Fig. 1C, D, and E) with 
no hemorrhagic transformation. 
We obtained written informed consent from the patient. This 
study was approved by the Institutional Review Board of Sam-
sung Medical Center (IRB No. 2015-04-091).
DISCUSSION
We report a case of focal high uptake of AV-1451 which was 
shown to be a subacute infarction. Although 18F-AV-1451 is a 
tau PET ligand that has high affinity for paired helical filament 
tau, various off-target bindings unrelated to tau have been re-
ported.3-5,9 The underlying substrate of AV-1451 off-target 
binding in the substantia nigra, basal ganglia, and choroid 
plexus are not well understood. Previous studies suggested that 
AV-1451 binds to neuromelanin containing neurons in the 
substantia nigra.4 Elevated in vivo AV-1451 uptake in the basal 
ganglia was observed in elderly individuals, which might be 
due to iron component or different kinetic profile of the tracer 
Fig. 1. Brain images of an 83-year old woman. (A) FLAIR showed subcortical white matter hyperintensities and no cortical lesions. (B) 18F-AV-1451 PET, 
taken 20 days after initial MRI, showed a focal hot uptake of AV-1451 in the left sensory cortex (arrows). SUVR was measured using cerebellar grey 
matter as the reference region. The patient was re-evaluated with brain MRI 30 days after 18F-AV-1451 PET. The left sensory cortical lesion was re-
vealed to be a subacute infarction. (C) Axial FLAIR image shows geographic hyperintensity involving the left primary sensory cortical region (arrow). 
(D) Diffusion weighted imaging shows restricted diffusion with high signal on the b600 image (arrow) and (E) isointense signal intensity on the appar-
ent diffusion coefficient map (arrow). FLAIR, fluid-attenuated inversion recovery; SUVR, standardized uptake value ratio.
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in the basal ganglia.5 Another AV-1451 off-target binding is the 
choroid plexus and the underlying substrate of tracer’s uptake 
is suggested to be leptomeningeal melanocyte or calcifica-
tions.4,5 AV-1451 uptake in the regions of meningiomas, vascu-
lar malformations, and remote infarcts3 has recently been re-
ported, and the authors suggested that increased vascular 
permeability was responsible for tracer retention. 
The reason why AV-1451 uptake was increased in ischemic 
stroke can be explained in several ways. AV-1451 might bind 
to tau in the area of the ischemic insult as a result of ischemic 
neuronal damage, apoptosis, or gliosis, which are reported to 
be associated with tau hyperphosphorylation.10 Alternatively, 
increased uptake of AV-1451 might be due to increased tracer 
leakage related to blood-brain-barrier dysfunction11 as it be-
comes permeable immediately after hypoxia-ischemia.12
Our present case is in line with a recent report showing two 
cases of elevated AV-1451 uptake in chronic infarction regions,3 
and the author suggested that vascular permeability might 
have contributed to AV-1451 retention. Similarly, a study of 
Pittsburgh compound B (PiB) PET showed focal PiB retention 
in subacute ischemic stroke regions, and the authors suggest-
ed leakage of PiB across the blood-brain barrier damaged by 
the ischemic process and reperfusion injury as a possible mech-
anism.13,14 However, controversies exist. In a larger study of 
subacute ischemic stroke patients, there was no significant in-
crease of PiB uptake in the infarct area.14
There are several limitations in this case report. First, the in-
terval between AV-1451 and brain MRI was quite long and we 
might have missed the acute stage of infarction. Second, we 
lacked pathology data to confirm the exact etiology of the AV-
1451 uptake. Therefore, our findings need to be further exam-
ined in a group of patients with ischemic stroke along with pa-
thology data. 
Nevertheless, we believe that this case is noteworthy because 
this is the first report to show increased AV-1451 uptake in a 
recent infarction area. We suggest that one should be cautious 
in the interpretation of increased AV-1451 uptake and that isch-
emic stroke should be considered as a possible cause.
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